Susan Serrao, Author at BioAegis Therapeutics https://www.bioaegistherapeutics.com/author/sserrao/ The Power of Innate Immunity Thu, 02 Apr 2020 13:08:09 +0000 en hourly 1 https://wordpress.org/?v=6.9.4 https://www.bioaegistherapeutics.com/wp-content/uploads/2020/02/cropped-BioAegis-Favicon500-32x32.webp Susan Serrao, Author at BioAegis Therapeutics https://www.bioaegistherapeutics.com/author/sserrao/ 32 32 December, 2019: BioAegis Therapeutics Announces Publication: “Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza” https://www.bioaegistherapeutics.com/news/december-2019-bioaegis-therapeutics-announces-publication-delayed-administration-of-recombinant-plasma-gelsolin-improves-survival-in-a-murine-model-of-severe-influenza/?utm_source=rss&utm_medium=rss&utm_campaign=december-2019-bioaegis-therapeutics-announces-publication-delayed-administration-of-recombinant-plasma-gelsolin-improves-survival-in-a-murine-model-of-severe-influenza Thu, 12 Dec 2019 15:47:59 +0000 https://www.bioaegistherapeutics.com/?p=897 MORRISTOWN, N.J., Dec. 12, 2019 (GLOBE NEWSWIRE) — BioAegis Therapeutics, Inc., a clinical stage company developing technology to address injurious inflammation while protecting immune function and vital organs in diseases driven by inflammation and infection, announces publication of new research findings with recombinant human plasma gelsolin in influenza. The research demonstrates that recombinant human plasma […]

The post December, 2019: BioAegis Therapeutics Announces Publication: “Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza” appeared first on BioAegis Therapeutics.

]]>